In vitro experiment demonstrates sustained nitric oxide release and antibacterial efficacy from engineered hydrogels, indicating broad biomedical utility.
Nitric oxide (NO)‐releasing materials have attracted considerable interest for their potential in diverse biomedical applications. However, a persistent challenge is the leaching of NO donors from these materials, which leads to significantly reduced NO release durations and undesirable burst release effects. Herein, we demonstrate a novel hydrogen‐bonding strategy to address NO donor leaching and the burst release of NO. A nitrosothiol‐based NO hydrogel was developed by incorporating a SNAP analog bearing a 4‐hydroxyphenethyl sidechain into polyvinyl alcohol (PVA)/PEG hydrogels. The hydrogel containing the structurally modified SNAP analog exhibited an elongation of over 300% and sustained NO release under physiological conditions. Hydrogen‐bonding interactions contributed to the enhanced retention of the SNAP analog within the hydrogel network, extending donor retention to 144 h compared with the hydrogel containing unmodified SNAP (10 h). These NO‐releasing hydrogels exhibited potent antibacterial activity against both S . aureus and E . coli , with bacterial reduction exceeding 99%, and caused pronounced disruption of surface‐associated bacterial structures. This novel hydrogen‐bonded NO donor–hydrogel system offers a promising strategy for durable and controlled NO release, with potential applications in wound dressings, tissue scaffolds, and flexible sensors.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: